Format

Send to

Choose Destination
Clin Cancer Res. 2014 May 1;20(9):2498-9. doi: 10.1158/1078-0432.CCR-13-2349.

Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letter.

Author information

1
Authors' Affiliations: Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
PMID:
24789037
DOI:
10.1158/1078-0432.CCR-13-2349
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center